News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (JOBS) Licenses Vaccine Candidates from US Group, AlphaVax, Inc. for $20 Million



12/29/2008 7:55:11 AM

ZURICH, Dec 29 (Reuters) - Novartis AG will license a programme of vaccines from U.S. group AlphaVax against cytomegalovirus (CMV) infections, which can cause disability in newborn babies, the Swiss drugmaker said on Monday.

Read at Reuters
Read at AP
Read at Bloomberg
Read at Trading Markets.com
Read at HAYS Pharma
Read at The Business Journals


comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES